Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Maintains Outperform on Otonomy, Raises Price Target to $6

Oppenheimer analyst Francois Brisebois maintains Otonomy (NASDAQ:OTIC) with a Outperform and raises the price target from $5 to $6.

April 21, 2022

1 minute read

Oppenheimer analyst Francois Brisebois maintains Otonomy (NASDAQ:OTIC) with a Outperform and raises the price target from $5 to $6.

Kodak Sets Its Sights On Digital Growth As It Announces Reseller Agreement With Production Print Solutions

Today, 11:34 PM

https://www.kodak.com/en/company/press-release/digital-growth-reseller-agreement

Today, 11:34 PM

https://www.pelobuddy.com/peloton-studios-summer-homecoming-2022/

Today, 11:34 PM

JMP Securities analyst Patrick Walravens maintains Asana (NYSE:ASAN) with a Market Outperform and raises the price target from $50 to $82.

Today, 11:34 PM

TD Securities maintains Equinix (NASDAQ:EQIX) with a Hold and raises the price target from $800 to $850.